Abstract
Aims: In the present study, we investigated whether rhein exerted hypoglycemic action and rhein’s effect on the pancreatic β cell in db/db mice. Materials and methods: Thirty 4-week-old db/db mice were randomized to treatment with rhein (120 mg/kg) (no.=15) and placebo (1% natrium cellulose solution) (no.=15) for 8 weeks, respectively. Fifteen age-matched non-diabetic littermates db/m mice treated with placebo were studied as non-diabetic control. After an 8-week treatment, ip glucose tolerance test (IPGTT) and arginine tolerance test were performed. Area under curve (AUC) of insulin levels in IPGTT was calculated to evaluate insulin secretory function. Immunohistochemical staining of insulin was performed to estimate β cell mass. TUNEL assay was performed to determine β cell apoptosis. Islet isolation and perifusion were performed to evaluate kinetics of insulin release in vitro, especially first-phase insulin. Results: Compared with control group, AUC of glucose concentrations significantly decreased in the rhein-treated group (p<0.05). Simultaneously, AUC of insulin levels increased in the rhein-treated group (p<0.05), especially in the first 30 min after glucose load. Perifusion showed that the rhein-treated group manifested a significantly increase of first-phase insulin secretion. Immunohistochemical study and TUNEL assay showed that rhein treatment greatly preserved β cell mass and inhibited β cell apoptosis. Conclusions: Rhein treatment significantly improved glucose-dependent and independent insulin secretion by preservation of β cell mass and inhibition of β cell apoptosis in db/db mice. The characteristics of rhein may make it a novel therapeutic means for preventing from or curing diabetes in the near future.
Similar content being viewed by others
References
Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM. An examination of beta-cell function measures and their potential use for estimating beta-cell mass. Diabetes Obes Metab 2008, 10(Suppl 4): 63–76.
Perseghin G, Caumo A, Arcelloni C, et al. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 2003, 26: 2112–8.
Korytkowski M, Thomas A, Reid L, Tedesco MB, Gooding WE, Gerich J. Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes. Diabetes Care 2002, 25: 1607–11.
Shao J, Iwashita N, Ikeda F, et al. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun 2006, 344: 1224–33.
Zhang XL, Guo XH, Liu ZH, et al. Rhein improves diabetic nephropathy in obese diabetic rats induced by low dose streptozotocin. Chin J Endocrinol Metab 2005, 21: 563–5.
Ying WX, Zhu CW, Li RZ. Effects of rhein on nonalcoholic steatohepatitis in rats. Zhonghua Gan Zang Bing Za Zhi 2007, 15: 869–70.
Menkes CJ, Borderie D, Hernvann A, Ekindjian O. Inhibition by rhein of nitrosothiol production of human chondrocytes from osteoarthritis in culture. Bull Acad Natl Med 1999, 183: 785–95.
Jia ZH, Liu ZH, Zheng JM, et al. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Exp Clin Endocrinol Diabetes 2007, 115: 571–6.
Huang YF, Liu ZH, Chen HP, et al. Improvement of diabetic metabolic disorders ameliorate the renal lesion in db/db mice: comparison between rhein and rosiglitazone. Chin J Nephrol Dial Transplant 2004, 13: 215–21.
Liu ZH, Li YJ, Chen ZH, Liu D, Li LS. Glucose transporter in human glomerularmesangial cells modulated by transforming growth factor-beta and rhein. Acta Pharmacol Sin 2001, 22: 169–75.
Zhu J, Liu Z, Huang H, et al. Rhein inhibits transforming growth factor beta1 induced plasminogen activator inhibitor-1 in endothelial cells. Chin Med J (Engl) 2003, 116: 354–9.
Zheng JM, Zhu JM, Li LS, Liu ZH. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol 2008, 153: 1456–64.
Guo XH, Liu ZH, Wang JP, et al. Rhein halts the progression of diabetic nephrology in NOD mice. Chin J Nephrol Dial Transplant 2002, 11: 11–5.
Shen JM, Deng YY, Ye TT, et al. Effect of Rhubarb against microinflammation and oxidative stress status in nondialysed patients with uremia. J Yunyang Medical College 2008, 27: 423–5.
Luo ZY, Huang X, Bao GR. ESR study on the scavenging effect of the main ingredients in rheum palmatum on superoxide anion radical. Chin Archives Tradit Chin Med 2007, 25: 612–4.
Sato H, Ishizawa F, Hirayama H, Hishinuma T, Mizugaki M. Extra-weak chemiluminescence of drugs. XIV. Quenching effects of anthraquinones on the extra-weak chemiluminescence from lipid peroxidation in rat brain homogenates. Yakugaku Zasshi 1992, 112: 199–202.
Author information
Authors and Affiliations
Corresponding author
Additional information
H.D. and J.S. contributed equally to this work
Rights and permissions
About this article
Cite this article
Du, H., Shao, J., Gu, P. et al. Improvement of glucose tolerance by rhein with restored early-phase insulin secretion in db/db mice. J Endocrinol Invest 35, 607–612 (2012). https://doi.org/10.1007/BF03345796
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345796